about
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesGenomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristicsRelation between the rate of tumour cell proliferation and latency time in radiation associated breast cancerMale gynecomastia and risk for malignant tumours--a cohort study.Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation statusAssociation between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma familiesDo both heterocyclic amines and omega-6 polyunsaturated fatty acids contribute to the incidence of breast cancer in postmenopausal women of the Malmö diet and cancer cohort?Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesA protein deep sequencing evaluation of metastatic melanoma tissuesGenome-wide association study identifies a new melanoma susceptibility locus at 1q21.3Genome-wide association study identifies three new melanoma susceptibility loci.Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.A variant in FTO shows association with melanoma risk not due to BMIIdentification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Molecular serum portraits in patients with primary breast cancer predict the development of distant metastasesAlcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the diseaseDevelopment and validation of a melanoma risk score based on pooled data from 16 case-control studies.Analysis of protein expression in pure cell nuclei populations isolated from human breast cancer tissue by DNA flow cytometric sorting.Analysis of Swedish male breast cancer family data: a simple way to incorporate a common sibling effect.Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study.Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.A review of the epidemiology of soft tissue sarcoma.Oral contraceptive use among young women in southern Sweden.High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer.An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study.Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer.Sunscreen use and malignant melanoma.Epithelial and stromal microRNA signatures of columnar cell hyperplasia linking Let-7c to precancerous and cancerous breast cancer cell proliferation.Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.Use of sunbeds or sunlamps and malignant melanoma in southern Sweden.Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer.Genetic testing for melanoma.Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules.The effect on melanoma risk of genes previously associated with telomere length.
P50
Q24531993-B5B1D00C-A93C-4F83-931E-B736D207C0BFQ24595882-51C8C7AE-49C9-48D7-B6B3-8E19A7EED59AQ24796728-0393C0FC-7A8A-4BCB-945E-29475ED9AF90Q24799414-4B85EDCF-C8A1-41C1-B9B7-56CFE7871F13Q24802534-AC85AD7D-8FBF-4B2C-A337-6583A7B438BFQ27851709-5C605FFC-505B-4FFB-8336-8188FDAED2ACQ28242124-0F0EE51A-593D-45DF-BC8A-2AACFE7FE677Q28287605-A7F60A3B-E237-426B-BB43-FAB68BBA27E4Q28388497-37317E74-435A-40BF-8D65-7CE251901181Q28546229-CD595BA2-A6B1-4706-91FB-765734ACCECEQ28943520-C5739DFE-D9DD-4B37-BED2-DD4F825CC474Q29416994-BA6E1210-26CD-4EF4-AAC0-F09E7AD6B5BDQ29417050-A2971614-1A54-4C40-9D1C-944C8B16BEF8Q29417157-765790DB-1914-4D6B-A42E-5CD7BBAADEF7Q30252854-62DC41BD-FB04-4538-B39C-421D4DF1F80FQ30503693-C7772279-F0A3-4843-A979-A7EE6822EF03Q30747351-E4B6CEC5-8008-4D9F-8BF5-4525E3B74976Q30899396-EEF7A3B8-86E4-4FDF-902F-06FB92D2189FQ30968129-C50C5202-B0D8-48D6-8A42-6D4194BAD37FQ32066874-4B0FA8D7-3054-4F55-B3AF-0F52B9EC3B44Q33313053-666F9CDE-C6B0-4781-AEEC-5849C2FB043FQ33425129-6B57345E-058B-4C78-A924-C626F512F40EQ33443484-1D1C744A-5A66-4ACD-9CD8-8C68EC6ADC81Q33605879-539E71A9-6AB1-43D3-96EA-2A985D94B72FQ33605879-F86FBCB6-8F15-475F-93A5-FEB085A067DEQ33701071-1F7F750D-4413-4121-A111-5E37833AC3B1Q33701567-5A1E7A51-8AFF-40BD-8B44-47FFD6DB1144Q33757555-5DBE1E10-2326-4279-AC4B-38477B9BBEB4Q33785471-2428D299-DDF0-42B4-A900-07EC415EFAA9Q33792814-77462059-1995-416B-97FB-58E7F0CE30DAQ33906437-25A9EBFD-C403-48BA-BE4C-D8C3A1AFBF7EQ34047424-06DDD128-C56E-4CE2-B6BE-3F254132FD53Q34048118-1359186B-19E9-415B-AD31-C6E3069BEA22Q34058682-D173BF1F-59F1-4A1E-AFD2-49728F17346AQ34059709-27D6A6A3-EE2A-432F-BDF5-B61C968DB680Q34083767-1498DF42-7EA4-4DC8-AD2B-428939644351Q34158316-932BC40D-7291-4202-A73D-901B89B31539Q34212766-9159FA1E-1863-499E-B9DA-D308AF4A6872Q34240064-57117A43-5839-4D1B-BB2B-44AF3A9923A8Q34243783-64C8A440-826D-4787-AAAE-A29F475BCD2E
P50
description
Zweeds onderzoeker
@nl
researcher ORCID ID = 0000-0002-8794-9635
@en
svensk forsker
@nb
name
Håkan Olsson
@ast
Håkan Olsson
@da
Håkan Olsson
@de
Håkan Olsson
@en
Håkan Olsson
@es
Håkan Olsson
@fr
Håkan Olsson
@ga
Håkan Olsson
@nb
Håkan Olsson
@nl
Håkan Olsson
@nn
type
label
Håkan Olsson
@ast
Håkan Olsson
@da
Håkan Olsson
@de
Håkan Olsson
@en
Håkan Olsson
@es
Håkan Olsson
@fr
Håkan Olsson
@ga
Håkan Olsson
@nb
Håkan Olsson
@nl
Håkan Olsson
@nn
prefLabel
Håkan Olsson
@ast
Håkan Olsson
@da
Håkan Olsson
@de
Håkan Olsson
@en
Håkan Olsson
@es
Håkan Olsson
@fr
Håkan Olsson
@ga
Håkan Olsson
@nb
Håkan Olsson
@nl
Håkan Olsson
@nn
P106
P1153
56929690100
57205203630
P21
P27
P31
P496
0000-0002-8794-9635